Loading...
Loading...
Application UK00917875592 · Registered
| Application Number | UK00917875592 |
| Status | Registered |
| Owner | CELLINK Bioprinting AB |
| Filed | 2018-03-16 |
| Registered | 2018-07-17 |
| Renewal Due | 2028-03-16 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Yes. SKIN X is currently a registered UK trademark, with renewal due on 2028-03-16. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Biologically compatible polymers, namely hydrogels used to produce polymeric networks for use in the manufacture of engineered living tissue for medical, scientific and non-scientific purposes; Cell culture medium for use in the biotechnology industry; Cell culture medium for use in non-medical research laboratories; Biological preparations for use in cell cultures, other than for medical or veterinary use; Engineered living tissue and tissue collections, namely human and animal organs, connective tissue, epithelial tissue, muscular tissue and nerve tissue, and tissue collections, for scientific and research use and Medical research; Biologically compatible materials, namely hydrogels used to produce polymeric networks for use in the manufacture of living tissue; Proteins in the form of raw materials for scientific and medical research.
Pharmaceutical preparations for use in the field of 3D bioprinting of tissue and organs; Pharmaceutical preparations based on cellulose nanofibril for use in 3D bioprinting tissue and organs; Tissue-regenerative pharmaceutical preparations; Cells for medical use; Human allograft tissue; Living cells for medical use; Implantation of living tissue with controlled tissue regeneration; Live tissue implants; Implantable materials consisting of living tissue for use in controlled tissue regeneration; Skin grafts; Surgical implants comprised of living tissues; Surgical implants obtained from stem cells; Transdermal patches for use in creating skin for prosthetics and skin grafts; Live tissue for grafts; Engineered biological tissue and organs, namely human and animal cardiovascular, lung, digestive, hepatobiliary, urological, renal, endocrine, epithelial, muscular and nerve tissue and organs, for medical purposes; Biological molecules to aid tissue development; Haemostatic gel matrix preparations for treating wounds; Natural biomaterial for bone, blood and tissue growth for medical purposes; Pharmaceutical preparations for regeneration, repair and treatment of both human and animal tissue; Pharmaceutical preparations for the treatment of bone diseases, For cartilage diseases, blood vessel diseases, nerve cell degeneration, tendon and ligament degeneration, retina degeneration, kidney degeneration; Soft tissue degeneration, diseases involving abnormal cell growth; Natural biomaterial for bone grafting; Natural biomaterial for grafting cartilage; Biological tissue cultures for medical purposes; Biological tissue cultures for medical purposes; Biological tissue transplants; Biological bone and skin tissue impregnated with oxygen lines, enabling the relevant tissue structures to increase cell survival in tissue intended for subsequent implant; Gene therapy products, Namely, Genetically engineered tissue for transplantation; Implantable frames containing live tissue for maintaining tissue structure; Natural biomaterial for bone and tissue growth for medical purposes.
'SKIN X' is a registered trademark on the UK IPO register, owned by CELLINK Bioprinting AB. The application (UK00917875592) was filed on 16 March 2018 and registered on 17 July 2018. The registration is set to expire on 16 March 2028.
This mark is recorded under multiple classes: Class 1 (chemicals for industrial, scientific & agricultural use); Class 5 (pharmaceuticals & medical preparations).
The trademark is represented by Zacco UK Ltd.
UK trademark UK00917875592 for the mark 'SKIN X' in Class 1, 5 is recorded on the UK IPO register as owned by CELLINK Bioprinting AB. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00917875592 for the mark 'SKIN X' as registered.
UK trademark UK00917875592 for the mark 'SKIN X' is recorded in Class 1 (chemicals for industrial, scientific & agricultural use); Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 1: Biologically compatible polymers, namely hydrogels used to produce polymeric networks for use in the manufacture of engineered living tissue for medical, scientific and non-scientific purposes; Cell culture medium for use in the biotechnology industry; Cell culture medium for use in non-medical research lab…
UK trademark UK00917875592 for the mark 'SKIN X' was filed at the UK IPO on 16 March 2018 and registered on 17 July 2018.
UK trademark UK00917875592 for the mark 'SKIN X' is currently recorded as valid until 16 March 2028, at which point it will need to be renewed with the UK IPO to remain in force.
Zacco UK Ltd is listed as the attorney / representative of record for UK trademark UK00917875592 for the mark 'SKIN X' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.